Angiogenesis in glioblastoma: just another moving target?
Weller
Michael
M
Department of Neurology, University Hospital Zurich, Zurich, Switzerland. michael.weller@usz.ch
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000818:Animals; D016503:Drug Delivery Systems / Q000639:trends; D005909:Glioblastoma / Q000098:blood supply* / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000378:metabolism
D020533:Angiogenesis Inhibitors